Lindbrook Capital’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $21.4K | Sell |
568
-46
| -7% | -$1.74K | ﹤0.01% | 1320 |
|
|
2024
Q4 | $50.3K | Sell |
614
-2
| -0.3% | -$164 | ﹤0.01% | 809 |
|
|
2024
Q3 | $70.4K | Sell |
616
-122
| -17% | -$13.9K | 0.01% | 682 |
|
|
2024
Q2 | $55.7K | Buy |
738
+325
| +79% | +$24.5K | 0.01% | 746 |
|
|
2024
Q1 | $28.2K | Buy |
413
+2
| +0.5% | +$137 | ﹤0.01% | 1040 |
|
|
2023
Q4 | $25.8K | Sell |
411
-4
| -1% | -$251 | ﹤0.01% | 1045 |
|
|
2023
Q3 | $21.2K | Buy |
415
+7
| +2% | +$357 | ﹤0.01% | 1033 |
|
|
2023
Q2 | $20.4K | Buy |
408
+81
| +25% | +$4.05K | ﹤0.01% | 1081 |
|
|
2023
Q1 | $12.3K | Buy |
327
+186
| +132% | +$6.97K | ﹤0.01% | 1319 |
|
|
2022
Q4 | $6.76K | Buy |
141
+103
| +271% | +$4.94K | ﹤0.01% | 1644 |
|
|
2022
Q3 | $1K | Buy |
38
+27
| +245% | +$711 | ﹤0.01% | 2447 |
|
|
2022
Q2 | $0 | Sell |
11
-58
| -84% | – | ﹤0.01% | 2715 |
|
|
2022
Q1 | $2K | Buy |
+69
| New | +$2K | ﹤0.01% | 2049 |
|
|
2021
Q3 | – | Sell |
-17
| Closed | – | – | 1972 |
|
|
2021
Q2 | $0 | Buy |
+17
| New | – | ﹤0.01% | 1983 |
|